Heparin-immobilized poly(2-hydroxyethylmethacrylate)-based microspheres

Abstract

Poly(2-hydroxyethylmethacrylate) (PHEMA)-based microspheres (150–200 µm in diameter) were produced by a modified suspension polymerization of different type of comonomers—namely, acrylic acid, dimethylaminoethyl-methacrylate, and methylmethacrylate. These microspheres were activated with cyanogen bromide (CNBr) at pH 11.5, and heparin molecules were then immobilized through covalent bonds. The amount of immobilized heparin was controlled by changing the initial concentration of CNBr and heparin. The increase in the initial concentrations of both CNBr and heparin caused an increase in the amount of heparin immobilized onto microspheres for all polymer surfaces. The maximum heparin immobilization was observed on the PHEMA homopolymer microspheres (180 mg/g). The plain and heparin-immobilized microspheres were contacted with blood in in vitro systems and in ex vivo animal experiments. Loss of the blood cells and clotting times were followed. Anticoagulant effect of the immobilized heparin was clearly observed with blood coagulation experiments. Loss of cells in the blood contacting with heparin-immobilized microspheres was significantly lower than those observed with the plain microspheres. Bovine serum albumin adsorption onto the microspheres containing heparin on their surfaces was also studied. High albumin adsorption values (up to 127 mg/g) were observed in which the heparin-immobilized PHEMA microspheres were used. © 1999 John Wiley & Sons, Inc. J Appl Polym Sci 74: 655–662, 1999